-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RyDqSbpksFohCT7CUM/zQoxP4RahHc7Q6BbJT0X9DB5qQiPlUy2EdwI1C75VUCcz J4taYncg7g0KEE+VpNAhMQ== 0001179350-03-000040.txt : 20030228 0001179350-03-000040.hdr.sgml : 20030228 20030228153238 ACCESSION NUMBER: 0001179350-03-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030227 FILED AS OF DATE: 20030228 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOTECHNOLOGY CORP CENTRAL INDEX KEY: 0000789097 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 841016435 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24641 FILM NUMBER: 03586595 BUSINESS ADDRESS: STREET 1: 1661 LAKEVIEW CIRCLE CITY: OGDEN STATE: UT ZIP: 84403 BUSINESS PHONE: 8013993632 FORMER COMPANY: FORMER CONFORMED NAME: LJC CORP DATE OF NAME CHANGE: 19891025 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTECHNOLOGY LABORATORIES INC DATE OF NAME CHANGE: 19900503 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SCHARMANN MARK A CENTRAL INDEX KEY: 0001031893 RELATIONSHIP: OFFICER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 4808 NORTH 22ND STREET STREET 2: CAPITAL TITLE GROUP INC CITY: PHOENIX STATE: AZ ZIP: 85016 BUSINESS PHONE: 6029540022 MAIL ADDRESS: STREET 1: C/O CAPITAL TITLE GROUP INC STREET 2: 1661 LAKEVIEW CIRCLE CITY: OGDEN STATE: UT ZIP: 84403 4 1 f4ms203.txt M. SCHARMANN FORM 4 1 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 1. Name and Address of Reporting Person: Mark A. Scharmann, 1661 Lakeview Circle, Ogden, UT 84403 2. Issuer Name and Ticker or Trading Symbol: ImmunoTechnology Corp ("IMNT") 3. IRS or Social Security Number of Reporting Person (Voluntary): 4. Statement for Month/Day/Year: 2/27/03 5. If Amendment, Date of Original (Month/Year): 6. Relationship of Reporting Person(s) to Issuer (Check all Applicable) ( ) Director (X) Officer, give title below (X) 10% Owner ( ) Other Title: President 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person TABLE I NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED 1. Title of Security: Common Stock 2. Transaction Date (Month/Day/Year): 10/03/02 3. Transaction Code: J 4. Securities Acquired (A) or Disposed of (D): Amount: (A) 1,292,989 5. Amount of Securities Beneficially Owned at End of Month: 5,944,673 6. Ownership Form: Direct (D) or Indirect (I): (D) 5,807,823 (I) 136,850 7. Nature of Indirect Beneficial Ownership: 86,850 shares held by Troika Capital, LLC, an entity controlled by the Reporting Person, and 50,000 shares held in the Reporting Person's IRA. TABLE II DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF OR BENEFICIALLY OWNED 1. Title of Derivative Security: 2. Conversion or Exercise Price of Derivative Security: 3. Transaction Date (Month/Day/Year): 4. Transaction Code: 5. Number of Derivative Securities Acquired (A) or Disposed of (D): 6. Date Exercisable and Expiration Date (Month/Day/Year): 7. Title and Amount of Underlying Securities: 8. Price of Derivative Security: 9. Number of Derivative Securities Beneficially Owned at End of Month: 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I): 11. Nature of Indirect Beneficial Ownership: Explanation of Responses: The securities were acquired in settlement of debt owed to the Reporting Person totaling $40,405.91 in principal and interest. Signature of Reporting Person: /S/Mark A. Scharmann Date: 2/27/03 -----END PRIVACY-ENHANCED MESSAGE-----